DNLI Q1 2025 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

DNLIDenali Therapeutics Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$146M

Net Income

-$133M

EPS (Diluted)

$-0.78

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$131M

Free Cash Flow

-$137M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$149M

Stockholders' Equity

$1.1B

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$146M	-$118M	-23.7%
Net Income	-$133M	-$102M	-30.6%